Additional Proxy Soliciting Materials (definitive) (defa14a)
2023年4月29日 - 5:34AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
| | | | | | | | | | | | | | |
Filed by the Registrant ☒ | | Filed by a Party other than the Registrant ☐ |
| | |
CHECK THE APPROPRIATE BOX: |
☐ Preliminary Proxy Statement |
☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☐ Definitive Proxy Statement |
☒ Definitive Additional Materials |
☐ Soliciting Material Under §240.14a-12 |
ImmunityBio, Inc.
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
| | |
PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY): |
☒ No fee required. |
☐ Fee paid previously with preliminary materials. |
☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
NantKwest (NASDAQ:NK)
過去 株価チャート
から 8 2024 まで 9 2024
NantKwest (NASDAQ:NK)
過去 株価チャート
から 9 2023 まで 9 2024
Real-Time news about NantKwest Inc (ナスダック市場): 0 recent articles
その他のImmunitybio, Inc.ニュース記事